Drug Profile
Women's health therapeutic (2) - Avion Pharmaceuticals
Latest Information Update: 10 Sep 2016
Price :
$50
*
At a glance
- Originator Unknown
- Developer Avion Pharmaceuticals
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Female genital diseases
Most Recent Events
- 09 Sep 2016 No recent reports on development identified - Clinical-Phase-Unknown for Gynaecological disorders in USA (unspecified route)
- 16 Jun 2014 Clinical trials in Gynaecological disorders in USA (unspecified route) before June 2014